Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Oct 19, 2015 at 11:50 AM EDT

Beigene Readies Itself for IPO

Beigene has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Chris Lange | Oct 19, 2015 at 8:35 AM EDT

Are Valeant Earnings Enough?

Valeant Pharmaceuticals reported its third-quarter financial results before the markets opened on Monday.

Chris Lange | Oct 17, 2015 at 10:20 AM EDT

5 Top Biotech Movers of the Past Week

Over the past week, a few biotech companies, such as Cepheid and Valeant Pharmaceuticals, made absolutely massive runs.

Chris Lange | Oct 16, 2015 at 12:35 PM EDT

PCT Therapeutics Rises on Analyst Upgrade

PTC Therapeutics traded higher Friday morning following the release of an incredibly positive analyst report.

Chris Lange | Oct 16, 2015 at 10:35 AM EDT

Cempra Slips on Phase 3 Results

Cempra made waves in the market on Friday morning on Phase 3 trial news. Despite announcing positive top-line results, shares…

Lee Jackson | Oct 16, 2015 at 9:25 AM EDT

Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings

These three top biotech names are very good bets for investors looking to add high-quality companies with less volatility and…

Jon C. Ogg | Oct 15, 2015 at 3:04 PM EDT

Why Analysts Will Have to Slash Their Hospital Price Targets

ThinkstockIn the world investing, a fire or problem at one company often means that its peers and rivals are likely…

Chris Lange | Oct 15, 2015 at 11:25 AM EDT

Appellis Pharma Files for IPO

Appellis Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering.

Chris Lange | Oct 15, 2015 at 10:25 AM EDT

Are UnitedHealth Earnings Enough for Investors?

ThinkstockUnitedHealth Group Inc. (NYSE: UNH) released its third-quarter financial results before the markets opened on Thursday. The health insurance giant…

Trey Thoelcke | Oct 15, 2015 at 8:45 AM EDT

How the Technology of One Small Biotech Can Save Tetraphase

Tetraphase Pharmaceuticals continues to reel from the spectacular and unexpected failure of its flagship candidate, eravacycline.

Chris Lange | Oct 14, 2015 at 1:10 PM EDT

What to Expect From UnitedHealth Earnings

UnitedHealth Group is scheduled to report its third-quarter financial results Thursday before the markets open.

Chris Lange | Oct 14, 2015 at 11:05 AM EDT

Axsome Therapeutics Files for IPO

Axsome Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Oct 13, 2015 at 11:45 AM EDT

Can-Fite Prepares for Secondary Offering

Can-Fite BioPharma announced that it has entered into definitive agreements with existing institutional investors in regard to a secondary offering.

Chris Lange | Oct 13, 2015 at 10:55 AM EDT

What Analysts Have to Say About Nabriva After Quiet Period

Nabriva Therapeutics entered the market in mid-September, and now the quiet period has passed, allowing the underwriters can make calls.

Chris Lange | Oct 13, 2015 at 10:10 AM EDT

Dimension Therapeutics Sets Terms for IPO

Dimension Therapeutics expects to offer 5.5 million shares within the price range of $14 to $16 in an IPO valued…

1 … 239 240 241 242 243 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Beigene Readies Itself for IPO

Are Valeant Earnings Enough?

5 Top Biotech Movers of the Past Week

PCT Therapeutics Rises on Analyst Upgrade

Cempra Slips on Phase 3 Results

Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings

Why Analysts Will Have to Slash Their Hospital Price Targets

Appellis Pharma Files for IPO

Are UnitedHealth Earnings Enough for Investors?

How the Technology of One Small Biotech Can Save Tetraphase

What to Expect From UnitedHealth Earnings

Axsome Therapeutics Files for IPO

Can-Fite Prepares for Secondary Offering

What Analysts Have to Say About Nabriva After Quiet Period

Dimension Therapeutics Sets Terms for IPO

AMZW’s Weekly Payouts Drop 79% as Volatility Collapses; Can Investors Count on Them?

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

AMZW’s Weekly Payouts Drop 79% as Volatility Collapses; Can Investors Count on Them?

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

Health and Healthcare Articles

All Health and Healthcare Articles

Beigene Readies Itself for IPO

Are Valeant Earnings Enough?

5 Top Biotech Movers of the Past Week

PCT Therapeutics Rises on Analyst Upgrade

Cempra Slips on Phase 3 Results

Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings

Why Analysts Will Have to Slash Their Hospital Price Targets

Appellis Pharma Files for IPO

Are UnitedHealth Earnings Enough for Investors?

How the Technology of One Small Biotech Can Save Tetraphase

What to Expect From UnitedHealth Earnings

Axsome Therapeutics Files for IPO

Can-Fite Prepares for Secondary Offering

What Analysts Have to Say About Nabriva After Quiet Period

Dimension Therapeutics Sets Terms for IPO

AMZW’s Weekly Payouts Drop 79% as Volatility Collapses; Can Investors Count on Them?

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how